—#97262

Product

Spectrum Central Venous Tray Minocycline/Rifampin Impregnated Triple Lumen Polyurethane Catheter, 7.0 Fr/ 15 cm Power Injectable, C-UTLMY-701J-ABRM-HC-IHI-FST-A-RD, G49803, Sterile, Cook Medical, Cook Incorporated, Bloomington, IN.

FDA product code: FOZ — Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days
Device class: Class 2
Medical specialty: General Hospital
510(k) numbers: K081113
Affected lot / code info: Part number: C-UTLMY-701J-ABRM-HC-IHI-FST-A-RD, Global part number G49803. Lot numbers: 2240346; 2241834; 2245786; 2248322; 2249284; 2251999; 2253344; 2255176; 2255741; 2259342; 2268075; 2269800; 2276914; 2277908; 2281660; 2282559; 2285525; 2286943; 2291838; 2293485; 2294042; 2297529; 2299454; 2303178; 2306599; 2309430; 2311594; 2315346; 2316748; 2317453; 2318707; 2318718; 2318843; 2321268; 2321271; 2321282; 2321283; 2321299; 2325081; 2325083; 2325094; 2329811; 2331460; 2335177.

Why it was recalled

Cook, Inc. is recalling Single, Double, Triple, and Five-Lumen Central Venous Catheter Trays AND Single and Double Lumen PICC Peripherally Inserted Central Venous Catheter Trays. These kits and trays contain 0.9% Sodium Chloride Injection USP 5 mL fill in 6 mL flush syringes that have been recalled by Excelsior Medical. During a routine test for syringe sterility, a possible integrity failure wa

Root cause (FDA determination)

Nonconforming Material/Component

Action the firm took

Cook, Inc. sent URGENT DEVICE RECALLS letters to its customers dated 10/4/2010. The letters asked customers to examine their inventory and notify Cook for product return. The letter included a response form.

Recalling firm

Firm: Cook, Inc.
Address: 750 Daniels Way, Bloomington, Indiana 47404-9120

Distribution

Distribution pattern: Worldwide distribution: USA, Chile, Colombia, Panama, Barbados, Canada, Guatemala, and Saudi Arabia.

Timeline

Recall initiated: 2010-10-04
Posted by FDA: 2011-02-23
Terminated: 2011-06-21
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #97262. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.